Testosterone Replacement Therapy Market Analysis, Share, Size and Forecasts to 2020

Technavio Announces the Publication of its Research Report – Global Testosterone Replacement Therapy Market 2016-2020

Technavio recognizes the following companies as the key players in the global testosterone replacement therapy market: AbbVie, Allergan, Eli Lilly, and Endo International.

Other Prominent Vendors in the market are: Acerus Pharmaceuticals, Antares Pharma, Bayer HealthCare Pharmaceuticals, Bedford Labs, Clarus Therapeutics, Ferring Pharmaceuticals, Forendo Pharma, Juniper Pharmaceuticals, Lipocine, MetP Pharma, Mylan, Pfizer, ProStrakan, Repros Therapeutics, Sandoz, TesoRx, and Teva Pharmaceuticals.

Browse full report with TOC@ https://marketreportscenter.com/reports/349446/global-testosterone-replacement-therapy-market-2016-2020

Commenting on the report, an analyst from Technavio’s team said: “Entry of SARMs will be a key trend for market growth. Testosterone therapies available as injectable or skin delivery formulations are currently used as androgen therapies. However, they are associated with side effects related to fluctuations in testosterone levels. The development and entry of SARMs in the market will serve as a better treatment option for androgen deficiencies. These drugs are available as orally active formulations and target androgen receptors specifically, thus eliciting the desired response in the body.”

According to the report, increase in older population will be a key driver for market growth. Age related lowering of testosterone presents features both primary and secondary hypogonadism. Improved healthcare infrastructure and sophisticated treatment facilities have increased life expectancy of individuals. This has led to an increase in older adult population worldwide.

Further, the report states that generic erosion will be a challenge for the market. The entry of generic drugs in the market results in the decline in the overall market revenue, thus affecting the growth of the market. Though all marketed drugs have...